Evidence map›Paper›PMID 39373358›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Injectable Magnetic Hydrogel Incorporated with Anti-Inflammatory Peptide for Efficient Magnetothermal Treatment of Endometriosis.

Huaichao Liu, Xiaohui Dai, Na Li, Le Zhang, Zihan Wang, Ke Ren, Yulei Li, Xiao Sun, Jipeng Wan

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Magnetic nanoparticles as promising materials for the future of medicine.Journal of materials science. Materials in medicine · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huaichao LiuDepartment of Gynecology, Ji Nan Key Laboratory of Diagnosis and Treatment of Major Gynaecological Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
Xiaohui DaiSchool of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250000, China.
Na LiDepartment of Gynecology, Ji Nan Key Laboratory of Diagnosis and Treatment of Major Gynaecological Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
Le ZhangDepartment of Gynecology, Ji Nan Key Laboratory of Diagnosis and Treatment of Major Gynaecological Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
Zihan WangDepartment of Gynecology, Ji Nan Key Laboratory of Diagnosis and Treatment of Major Gynaecological Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
Ke RenSchool of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250000, China.
Yulei LiDepartment of Gynecology, Ji Nan Key Laboratory of Diagnosis and Treatment of Major Gynaecological Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
Xiao SunDepartment of Gynecology, Ji Nan Key Laboratory of Diagnosis and Treatment of Major Gynaecological Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.ORCID 0000-0001-6506-1574
Jipeng WanDepartment of Gynecology, Ji Nan Key Laboratory of Diagnosis and Treatment of Major Gynaecological Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.ORCID 0009-0003-7585-6735

Funding

National Natural Science Foundation of China 81801476Natural Science Foundation of Shandong ZR2023MH326Taishan Scholar Foundation of Shandong Province tsqn202408248
6 · The paper itself

Abstract

Endometriosis is a prevalent gynecological condition characterized by chronic pelvic pain, dysmenorrhea, and infertility, affecting ≈176 million women of reproductive age worldwide. Current treatments, including pharmacological and surgical interventions, are often associated with significant side effects and high recurrence rates. Consequently, there is an urgent need for innovative and safer therapeutic approaches. In this study, an injectable magnetic hydrogel nanosystem is developed designed for the dual-purpose magnetothermal and anti-inflammatory treatment of endometriosis. This hydrogel incorporates Fe

Indexed as

Anti-Inflammatory AgentsEndometriosisHydrogelsAnimalsDisease Models, AnimalFemaleHumansMicePeptidesAnti-Inflammatory AgentsHydrogelsPeptidesanti‐inflammatory therapydrug releaseendometriosisinjectable hydrogelmagnetothermal treatment

Identifiers

PMID39373358
PMCPMC11600196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.